SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001558370-22-009706
Filing Date
2022-06-03
Accepted
2022-06-03 12:46:39
Documents
13
Period of Report
2022-06-01
Items
Item 4.01: Changes in Registrant's Certifying Accountant
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K tmb-20220601x8k.htm   iXBRL 8-K 43336
2 EX-16.1 tmb-20220601xex16d1.htm EX-16.1 4161
  Complete submission text file 0001558370-22-009706.txt   169399

Data Files

Seq Description Document Type Size
3 EX-101.SCH tmb-20220601.xsd EX-101.SCH 3027
4 EX-101.LAB tmb-20220601_lab.xml EX-101.LAB 15922
5 EX-101.PRE tmb-20220601_pre.xml EX-101.PRE 10048
7 EXTRACTED XBRL INSTANCE DOCUMENT tmb-20220601x8k_htm.xml XML 4802
Mailing Address 44 MILTON AVENUE ALPHARETTA GA 30009
Business Address 44 MILTON AVENUE ALPHARETTA GA 30009 8666208655
Virios Therapeutics, Inc. (Filer) CIK: 0001818844 (see all company filings)

IRS No.: 854314201 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-39811 | Film No.: 22993557
SIC: 2834 Pharmaceutical Preparations